Pembrolizumab Biosimilar - Research Grade
€ Preis anfragen //= __('Ask for price', \GentaurWPMain\Includes\Gentaur::PLUGIN_ID) ?> //= $prices ?>
Detects human PD-1. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Pembrolizumab.
Low endotoxin, Biosimilar, recombinant antibody
Pembrolizumab biosimilar is a humanized monoclonal antibody that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2. It is an IgG4 kappa immunoglobulin with an approximate molecular weight of 149 kDa.